Bacterial deficiency as a diagnostic marker for colorectal cancer
- Summary
- This technology identifies a correlation between butyrate-producing bacteria and colorectal cancer that may serve as a diagnostic method and therapeutic platform.
- Technology Benefits
- Potential for earlier detection of colorectal cancerMay reduce misdiagnosesNon-invasiveButyrate or butyrate-producing bacteria can be easily reintroduced into the gastrointestinal tract for treatment
- Technology Application
- Diagnostic marker for CIMP-related colorectal cancerResearch tool to study the mechanism of CIMP formationTherapeutic platform for prevention and treatment of CIMP
- Detailed Technology Description
- None
- *Abstract
-
None
- *Inquiry
- Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- CU15016
- *Principal Investigator
-
- *Publications
- Tech Ventures Reference:IR CU15016Licensing Contact: Ron Katz
- Country/Region
- USA

For more information, please click Here